Abstract
The detrimental effects of heavy drinking and smoking are multiplied when the two are combined. Treatment modalities for each and especially for the combination are very limited. Although in low concentration, alcohol and nicotine, each may have beneficial effects including neuroprotection, their combination, instead of providing additive protection, may actually lead to toxicity in cell cultures. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous 38 amino-acid peptide with demonstrated protection against neuronal injury, trauma as well as various endogenous and exogenous toxic agents. The aim of this study was to investigate whether PACAP may also protect against toxicity induced by high alcohol, high nicotine, or the combination of low alcohol and nicotine concentrations, and if so, whether this effect was mediated via PAC1 receptor. We used the neuroblastoma-derived SH-SY5Y cells and applied various colorimetric assays for determination of cell viability or toxicity. Results indicate that PACAP blocks toxicity induced by high alcohol and high nicotine as well as their combination at low concentrations. The effects of PACAP in turn were blocked by the PACAP antagonist (PACAP 6-38), indicating involvement of the PACAP receptor PAC1 and possibly vasoactive intestinal peptide (VIP) receptors in PACAP’s protection. Moreover, no combined toxicity of low alcohol and low nicotine could be detected in calcium-free medium. These findings suggest possible beneficial effects of PACAP in preventing alcohol and nicotine toxicity and that calcium contributes to the damage induced by combination of low alcohol and nicotine in SH-SY5Y cells.
References
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, La Vecchia C (2015) Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer 112:580–593
Brown D, Tamas A, Reglodi D, Tizabi Y (2014) PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson’s disease. J Mol Neurosci 50:600–607
Casañas-Sánchez V, Pérez JA, Quinto-Alemany D, Díaz M (2016) Sub-toxic ethanol exposure modulates gene expression and enzyme activity of antioxidant systems to provide neuroprotection in hippocampal HT22 cells. Front Physiol 7:312
Churchill EN, Disatnik MH, Budas GR, Mochly-Rosen D (2008) Ethanol for cardiac ischemia: the role of protein kinase c. Ther Adv Cardiovasc Dis 2:469–483
Connor J (2017) Alcohol consumption as a cause of cancer. Addiction 112:222–228
Copeland RL, Das JR, Kanaan YM, Taylor RE, Tizabi Y (2007) Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res 12:61–69
Crews FT (2008) Alcohol-related neurodegeneration and recovery: mechanisms from animal models. Alcohol Research Health 31:377–388
Dietary Guidelines for Americans 2015-2020 (2015) U.S. Department of Health and Human Services and U.S. Department of Agriculture. Eighth edition Dietary Guidelines.gov
Donahue RJ, Venkataraman A, Carroll FI, Meloni EG, Carlezon WA Jr (2016) Pituitary adenylate cyclase-activating polypeptide disrupts motivation, social interaction, and attention in male Sprague Dawley rats. Biol Psychiatry 80:955–964
Dwivedi S, Goel A, Mandhani A, Khattri S, Pant KK (2012) Tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in north Indian population. Toxicol Int 19:310–318
Fontes-Júnior EA, Maia CSF, Fernandes LMP, Gomes-Leal W, Costa-Malaquias A, Lima RR, Crespo-López ME (2016) Chronic alcohol intoxication and cortical ischemia: study of their comorbidity and the protective effects of minocycline. Oxidative Med Cell Longev 2016:1341453
Hammack SE, May V (2015) Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies. Biol Psychiatry 78:167–177
Hopf FW (2016) Do specific NMDA receptor subunits act as gateways for addictive behaviors? Genes Brain Behav
Hurley LL, Taylor RE, Tizabi Y (2012) Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. Neurotox Res 21:57–69
Krenz M, Korthuis RL (2012) Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol 52:93–104
Lacaille H, D Duterte-Boucher, H Vaudry, Y Zerdoumi, JM Flaman, H Hashimoto and D Vaudry (2016) PACAP protects the adolescent and adult mice brain from ethanol toxicity and modulates distinct sets of genes regulating similar networks. Mol Neurobiol
Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, Jiang NS (1998) Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 38:502–509
Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R (2006) Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol Cell Neurosci 31:193–201
Maasz G, Zrinyi Z, Reglodi D, Petrovics D, Rivnyak A, Kiss T, Jungling A, Tamas A, Pirger Z (2017) Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models. Dis Model Mech 10:127–139
Masuo Y, Ohtaki T, Masuda Y, Tsuda M, Fujino M (1992) Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res 575:113–123
Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643–648
Monaghan TK, Mackenzie CJ, Plevin R, Lutz EM (2008) PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J Neurochem 104:74–88
Możdżeń E, Kajta M, Wąsik A, Lenda T, Antkiewicz-Michaluk L (2015) Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system. Neurotox Res 27:300–313
Qualls Z, Brown D, Ramlochansingh C, Hurley LL, Tizabi Y (2014) Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson’s disease. Neurotox Res 25:81–89
Quik M, Bordia T, Zhang D, Perez XA (2015) Nicotine and nicotinic receptor drugs: potential for Parkinson’s disease and drug-induced movement disorders. Int Rev Neurobiol 124:247–271
Ramlochansingh C, Taylor RE, Tizabi Y (2011) Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated. Neurotox Res 20:263–269
Reglodi D, J Renaud, A Tamas, Y Tizabi, SB Socías, E Del-Bel and R Raisman-Vozari (2015) Novel tactics for neuroprotection in Parkinson’s disease: Role of antibiotics, polyphenols and neuropeptides. Prog Neurobiol
Reglodi D, Tamás A, Lubics A, Szalontay L, Lengvári I (2004) Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats. Regul Pept 123:85–94
Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17:204–214
Sewram V, Sitas F, O’Connell D, Myers J (2016) Tobacco and alcohol as risk factors for oesophageal cancer in a high incidence area in South Africa. Cancer Epidemiol 41:113–121
Su F, AC Guo, WW Li, YL Zhao, ZY Qu, YJ Wang and YL Zhu (2016) Low-dose ethanol preconditioning protects against oxygen-glucose deprivation/reoxygenation-induced neuronal injury by activating large conductance, Ca (2+)-activated K (+) channels in vitro. Neurosci Bull
Tizabi Y (2016) Duality of antidepressants and neuroprotectants. Neurotox Res 30:1–13
Tizabi Y, Getachew B (2017) Nicotinic receptor intervention in Parkinson’s disease: future directions. Clin Pharmacol Transl Med 1-6
Vaudry D, Rousselle C, Basille M, Falluel-Morel A, Pamantung TF, Fontaine M, Gonzalez BJ (2002) Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci U S A 99:6398–6403
Venkataraman A, N Kalk, G Sewell, CW Ritchie and A Lingford-Hughes (2016) Alcohol and Alzheimer’s disease—does alcohol dependence contribute to beta-amyloid deposition, neuroinflammation and neurodegeneration in Alzheimer’s disease? Alcohol and Alcoholism
Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229–240
Yaegashi Y, Onoda T, Morioka S, Hashimoto T, Takeshita T, Sakata K, Tamakoshi A (2014) Joint effects of smoking and alcohol drinking on esophageal cancer mortality in Japanese men: findings from the Japan collaborative cohort study. Asian Pac J Cancer Prev 15:1023–1029
Zhang Y, Wang R, Miao L, Zhu L, Jiang H, Yuan H (2015) Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013. PLoS One 10:e0124045
Acknowledgements
Supported by: NIH/NIAAA R03AA022479 (YT); DC-IDDRC 1U54HD090257-01 (YT & ABC); Hungarian Brain Research Program (Grant No. KTIA_13_NAP-A-III/5), TAMOP 4.2.4.A/2-11-1-2012-0001, National Excellence Program and New National Excellence Program of the Ministry of Human Capacities (AT, UNKP-16-3-IV), and Centre for Neuroscience, University of Pecs (RD, AT, SM), GINOP-2.3.2-15-2016-00050 “PEPSYS” (RD, AT, SM), OTKA K104984, K119759) (AT, DR); NIH/NIA 1R25AG047843-01 and 1R03G049288-01A1 (KM), NIH/NIA R21AG047474 and AHA grant-in-aid 16GRNT31030019 (SJK).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manavalan, S., Getachew, B., Manaye, K.F. et al. PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity. Neurotox Res 32, 8–13 (2017). https://doi.org/10.1007/s12640-017-9727-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-017-9727-8